Small Molecule Inhibitors Targeting New Targets of Protein-Protein Interactions

作者: Liyan Yue , Wei Wan , Pan Xu , Linjuan Li , Chen Wang

DOI: 10.1007/978-981-13-0773-7_7

关键词: Rtk signalingSmall moleculeEpigeneticsChemistryProtein degradationProtein–protein interactionComputational biology

摘要: Targeting protein-protein interactions by small molecule compounds is challenging; however, exciting achievements have been made over the past decade. New targets of PPIs were identified, and lots modulators developed. In this chapter, we make a brief review research into their inhibitors. We focus on progress in some new involving biological processes such as epigenetic modification, ubiquitin-mediated protein degradation, immune response, RTK signaling pathway, copper transport. These case studies may provide researchers with basic overview area. Several other promising are also discussed herein.

参考文章(187)
Peter W. White, Anne-Marie Faucher, Nathalie Goudreau, Small molecule inhibitors of the human papillomavirus E1-E2 interaction. Current Topics in Microbiology and Immunology. ,vol. 348, pp. 61- 88 ,(2010) , 10.1007/82_2010_92
Dhulfiqar Ali Abed, Melanie Goldstein, Haifa Albanyan, Huijuan Jin, Longqin Hu, Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B. ,vol. 5, pp. 285- 299 ,(2015) , 10.1016/J.APSB.2015.05.008
Victoria Richmond, Flavia Michelini, Carlos Bueno, Laura Alche, Javier Ramirez, Small Molecules as Anti-TNF Drugs. Current Medicinal Chemistry. ,vol. 22, pp. 2920- 2942 ,(2015) , 10.2174/0929867322666150729115553
Rossella Pellegrino, Diego F. Calvisi, Olaf Neumann, Venkatesh Kolluru, Josephine Wesely, Xin Chen, Chunmei Wang, Torsten Wuestefeld, Sara Ladu, Nahla Elgohary, Justo Lorenzo Bermejo, Bernhard Radlwimmer, Martin Zörnig, Lars Zender, Frank Dombrowski, Matthias Evert, Peter Schirmacher, Thomas Longerich, EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma. Hepatology. ,vol. 59, pp. 1886- 1899 ,(2014) , 10.1002/HEP.26954
G. E. Winter, D. L. Buckley, J. Paulk, J. M. Roberts, A. Souza, S. Dhe-Paganon, J. E. Bradner, Phthalimide conjugation as a strategy for in vivo target protein degradation Science. ,vol. 348, pp. 1376- 1381 ,(2015) , 10.1126/SCIENCE.AAB1433
Krzysztof M. Zak, Radoslaw Kitel, Sara Przetocka, Przemyslaw Golik, Katarzyna Guzik, Bogdan Musielak, Alexander Dömling, Grzegorz Dubin, Tad A. Holak, Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. Structure. ,vol. 23, pp. 2341- 2348 ,(2015) , 10.1016/J.STR.2015.09.010
Florian Grebien, Masoud Vedadi, Matthäus Getlik, Roberto Giambruno, Amit Grover, Roberto Avellino, Anna Skucha, Sarah Vittori, Ekaterina Kuznetsova, David Smil, Dalia Barsyte-Lovejoy, Fengling Li, Gennadiy Poda, Matthieu Schapira, Hong Wu, Aiping Dong, Guillermo Senisterra, Alexey Stukalov, Kilian V M Huber, Andreas Schönegger, Richard Marcellus, Martin Bilban, Christoph Bock, Peter J Brown, Johannes Zuber, Keiryn L Bennett, Rima Al-awar, Ruud Delwel, Claus Nerlov, Cheryl H Arrowsmith, Giulio Superti-Furga, Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia Nature Chemical Biology. ,vol. 11, pp. 571- 578 ,(2015) , 10.1038/NCHEMBIO.1859
Rafik Salama, Norma Masson, Peter Simpson, Lina Katrin Sciesielski, Min Sun, Ya-Min Tian, Peter John Ratcliffe, David Robert Mole, Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer PLOS ONE. ,vol. 10, pp. e0134645- ,(2015) , 10.1371/JOURNAL.PONE.0134645
Cecile M. Pickart, Mechanisms underlying ubiquitination. Annual Review of Biochemistry. ,vol. 70, pp. 503- 533 ,(2001) , 10.1146/ANNUREV.BIOCHEM.70.1.503
Bowen Xu, Kyle D. Konze, Jian Jin, Gang Greg Wang, Targeting EZH2 and PRC2 dependence as novel anticancer therapy. Experimental Hematology. ,vol. 43, pp. 698- 712 ,(2015) , 10.1016/J.EXPHEM.2015.05.001